RNA
NSDAvidity Biosciences Inc.
Manufacturing•Pharmaceutical Preparation Manufacturing
Watchlists:
Last updated: Friday 18th July 2025
34.04
+0.51 (1.52%)
Prev Close:33.53
Open:33.45
Bid:34.04
Ask:34.5
52 Week Range
21.5156.00
Volume:1,516,177
Mkt Cap:3,821 M
75
MarketXLS Rank ®
Buy
Price Target
$39.15
+15.0%
Valuation
453.28
0.00
Range data not available
Returns
8.17%
15.94%
19.35%
-24.57%
104.44%
45.78%
17.06%
Risk
Risk Metrics
Financial Scores
-3.66
15.45
Ranks
Financial Scores
Risk Metrics
Dividends
Dividend Metrics
Dividend Yields
Analyst Estimates
EPS Estimates
Target Prices
Growth Estimates
Financial Health
Cash Metrics
Liquidity Ratios
16.90
16.30
Debt Metrics
Other Metrics
Financial Scores
4.0
Technicals
Technical Oscillators
Moving Averages
Volatility Metrics
Growth
EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A
Profitability
Return Ratios
Margin Ratios
-4227.5
100.0
Financial Scores
Peers
Financial Statements
RNA - Income Statement (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Invalid date | |
|---|---|---|---|---|---|---|
| Depreciation And Amortization | 3 M | 2 M | 1 M | 600000.0 | 400000.0 | |
| Gain On Sale Of Security | 57 M | 24 M | 5 M | 104000.0 | 206000.0 | |
| General And Administrative Expense | 86 M | 54 M | 38 M | 26 M | 13 M | |
| Gross Profit Margin (profit Margin After CGS) | 11 M | 10 M | 9 M | 9 M | 7 M | |
| Interest Expense Non Operating | 209000.0 | |||||
| Misc Other Special Charges | -248000.0 | -594000.0 | -57000.0 | -62000.0 | -75000.0 | |
| Net Income (loss) | -322 M | -212 M | -174 M | -118 M | -44 M | |
| Net Income Common Stockholders | -322 M | -212 M | -174 M | -118 M | -44 M | |
| Net Income Continuous Operations | -322 M | -212 M | -174 M | -118 M | -44 M | |
| Net Non Operating Interest Income Expense | -24 M | -5 M | -209000.0 | |||
| Normalized Income | -330 M | |||||
| Operating Income | -379 M | -236 M | -179 M | -118 M | -44 M | |
| Operating Income Before Depreciation (EBITDA) | -324 M | -213 M | -182 M | -117 M | -44 M | |
| Operating Expense | 390 M | 245 M | 188 M | 127 M | 51 M | |
| Other Gand A | 86 M | 54 M | 38 M | 26 M | 13 M | |
| Other Operating Expenses | -11 M | -6 M | -3 M | -1 M | -446000.0 | |
| Research Expense | 304 M | 191 M | 150 M | 101 M | 38 M | |
| Salaries And Wages | 51 M | 38 M | 27 M | |||
| Total Income Available For Interest Expense (EBIT) | -330 M | -218 M | -186 M | -118 M | -44 M | |
| Total Revenues | 11 M | 10 M | 9 M | 9 M | 7 M | |
| Total Expenses | 390 M | 245 M | 188 M | 127 M | 51 M | |
| Total Revenue | 11 M | 10 M | 9 M | 9 M | 7 M | |
| Avgshs | 112 M | 73 M | 52 M | 41 M | 22 M | |
| Avgshsdt | 112 M | 73 M | 52 M | 41 M | 22 M | |
| Basiceps | -2.89 | -2.91 | -3.34 | -2.85 | -2.05 | |
| Basicepscont | -2.89 | -2.91 | -3.34 | -2.85 | -2.05 | |
| Depamor | 3 M | 2 M | 1 M | 600000.0 | 400000.0 | |
| Dileps | -2.89 | -2.91 | -3.34 | -2.85 | -2.05 | |
| Dilepscont | -2.89 | -2.91 | -3.34 | |||
| Netincdisc | -322 M | -212 M | -174 M | -118 M | -44 M | |
| Othincexp | -57 M | -23 M | -57000.0 | 140000.0 | -126000.0 | |
| Pretaxinc | -322 M | -212 M | -174 M | -118 M | -44 M | |
| Resdev | 304 M | 191 M | 150 M | 101 M | 38 M | |
| Sga | 86 M | 54 M | 38 M | 26 M | 13 M | |
| Shsout | 120 M | 121 M | 71 M | 48 M | 38 M | |
| Taxprov | -8 M | -6 M | -12 M | -8 M | -3 M |